Document is current
Any future updates will be listed below
-
Authors
Takei, Hisashi
Fukuda, Hirofumi
Pan, Gilbert
Yamazaki, Hiroyuki
Matsumoto, Tadahiko
Kazuma, Yasuhiro
Fujii, Masanori
Nakayama, Sohei
Kobayashi, Ikei S.
Shindo, Keisuke
Yamashita, Riu
Shirakawa, Kotaro
Takaori-Kondo, Akifumi
Kobayashi, Susumu S. https://orcid.org/0000-0003-2262-4001
-
Funding
Funding for this research was provided by:
National Institutes of Health (R21CA178301, R01CA169259)
American Cancer Society (RSG-13-047)
Harvard Stem Cell Institute (DP-0110-12-00)
- License Information
-
More Information
Article History
Received: 7 November 2019
Revised: 8 May 2020
Accepted: 29 May 2020
First Online: 12 June 2020
Compliance with ethical standards
:
: Dr. Kobayashi reports grants and personal fees from Boehringer Ingelheim, grants from Taiho Pharmaceutical, grants from MiNA therapeutics, personal fees from Pfizer, personal fees from Ono, personal fees from Chugai, personal fees from Astra Zeneca, and personal fees from Roche, outside the submitted work. Dr. Yamashita reports personal fees from Takeda Pharm., outside the submitted work. The other authors declare no relevant conflict of interest.
